CreditReports.dk
HomeScreen companies

BARKA Therapeutics ApS Financials, key figures and credit report

CVR number: 44860627 Established 2024 Industry: 72 Scientific research and development
Company contact details
Slotsmarken 11, 2970 Hørsholm kab@hannibal-innovation.com tel: 21678077
Gross profit - 961.5 kDKK FY 2025 -1,792.1% vs 2024
EBIT - 961.5 kDKK FY 2025 -1,792.1% vs 2024
Net debt - 479.7 kDKK FY 2025 +69.7% vs 2024
Quick ratio 17.7 FY 2025 -12.3 vs 2024

Income statement (kDKK)

2024
2025
Fiscal period length1212
Net sales
External services-50.82- 961.54
Gross profit-50.82- 961.54
EBIT-50.82- 961.54
Other financial expenses-70.36- 125.14
Pre-tax profit- 121.18-1 086.68
Income taxes6.74205.92
Net earnings- 114.44- 880.76

Assets (kDKK)

2024
2025
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables7.66152.04
Current deferred tax assets6.74205.92
Short term receivables total14.39357.96
Cash and bank deposits1 584.80479.71
Cash and cash equivalents1 584.80479.71
Balance sheet total (assets)1 599.19837.66

Equity and liabilities (kDKK)

2024
2025
Share capital60.0060.00
Share premium account330.00330.00
Retained earnings- 114.44
Profit of the financial year- 114.44- 880.76
Shareholders equity total275.56- 605.21
Non-current deferred tax liabilities1 270.361 395.50
Non-current liabilities total1 270.361 395.50
Current trade creditors53.2832.38
Other non-interest bearing current liabilities15.00
Current liabilities total53.2847.38
Balance sheet total (liabilities)1 599.19837.66
Page generated